Guardrails for the use of generalist AI in cancer care

Research output: Contribution to journalComment/debateContributedpeer-review

Contributors

Abstract

Artificial narrow intelligence models, trained for specific intended purposes, have gained approval and recommendation for cancer treatment. Generalist medicial artificial intelligence (GMAI) models are now being developed for cancer treatment. Policy makers have a stark choice: radically adapt frameworks, block generalist approaches or force them onto narrower tracks.

Details

Original languageEnglish
Pages (from-to)357-358
Number of pages2
JournalNature Reviews Cancer
Volume24
Issue number6
Early online date16 Apr 2024
Publication statusPublished - Jun 2024
Peer-reviewedYes

Keywords

Sustainable Development Goals

ASJC Scopus subject areas